HuGE Literature Finder
Records 1-4
HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma.
Journal of cancer research and clinical oncology 2021 Feb . Liu Zimin, Shi Mingpeng, Li Xiaoxiao, Song Shanai, Liu Ning, Du Haiwei, Ye Junyi, Li Haiyan, Zhang Zhou, Zhang |
High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer.
Scientific reports 2019 Jul 9 (1): 10966. Lee Seung Eun, Lee Hye Seung, Kim Kyoung-Yeon, Park Jung-Hoon, Roh Hanseong, Park Ha Young, Kim Wan-Se |
Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population.
Carcinogenesis 2013 Jul 34 (7): 1536-42. Li Wen-Qing, Hu Nan, Hyland Paula L, Gao Ying, Wang Zhao-Ming, Yu Kai, Su Hua, Wang Chao-Yu, Wang Le-Min, Chanock Stephen J, Burdett Laurie, Ding Ti, Qiao You-Lin, Fan Jin-Hu, Wang Yuan, Xu Yi, Shi Jian-Xin, Gu Fangyi, Wheeler William, Xiong Xiao-Qin, Giffen Carol, Tucker Margaret A, Dawsey Sanford M, Freedman Neal D, Abnet Christian C, Goldstein Alisa M, Taylor Philip |
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.
The oncologist 2012 17 (1): 72-9. Borger Darrell R, Tanabe Kenneth K, Fan Kenneth C, Lopez Hector U, Fantin Valeria R, Straley Kimberly S, Schenkein David P, Hezel Aram F, Ancukiewicz Marek, Liebman Hannah M, Kwak Eunice L, Clark Jeffrey W, Ryan David P, Deshpande Vikram, Dias-Santagata Dora, Ellisen Leif W, Zhu Andrew X, Iafrate A Jo |
- Page last reviewed:Oct 1, 2020
- Page last updated:Feb 24, 2021
- Content source: